title: [Myasthenia syndrome after peroral treatment with penicillamine].
abstract: A 59-year-old woman has been treated for 5 months with penicillamine for a rheumatoid arthritis and developed a myasthenia syndrome with ptosis, diplopia, dysphagia and asthenia. This myasthenia was slowly cured after suppression of the penicillamine and administration of Mestinon, so that after 3 months, the anticholinesterase medication could be stopped.
mesh_terms: D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001763:Blepharoptosis / Q000139:chemically induced; D005260:Female; D006801:Humans; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000139:chemically induced*; D010396:Penicillamine / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D010396:Penicillamine
vernacular_title: Syndrome myasthénique après traitement peroral à la pénicillamine.